Therefore, these genes may be introduced as potential biomarkers for HCC, including TOP2A (p < 0.05), CDK1 (p < 0.05), CCNA2 (p < 0.05), and CCNB2 (p < 0.05) among other ones (Figure 4). This evidence concerns the gene CCNB2 and hepatocellular carcinoma.